The importance for prescribers to document and justify all prescribing decisions for unlicensed/off label use is paramount for good clinical governance standards
Within 10 years of T2DM diagnosis, 24.9% of people develop microalbuminuria, 5.3% develop macroalbuminuria, and 0.8% develop advanced CKD that includes persistently elevated plasma creatinine or the need for renal replacement therapy [4]
You're drinking water
Retatrutide does not currently have a legitimate retail price, so it is not accurate to describe it as expensive or inexpensive in the ordinary prescription-drug marketplace
So if you do it without any interaction or intervention, you're likely to have increased side effects
Shao ZM, Yao JF, Chen J, Yu ZW, Yu XF, Zheng JJ, et al